首页> 外文OA文献 >Erratum. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839–848

【2h】

Erratum. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839–848

机译：错误。 Liraglutide对参与者中淀粉酶，脂肪酶和急性胰腺炎的影响，来自超重/肥胖和常规血糖，前脂肪酸或2型糖尿病：来自规模临床发展计划的汇总数据的二次分析。糖尿病护理2017; 40：839-848

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
William M. Steinberg; Julio Rosenstock; Thomas A. Wadden; Morten Donsmark; Christine B. Jensen; J. Hans DeVries;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program (vol 40, pg 839, 2017) [J] . Steinberg William M., Rosenstock Julio, Wadden Thomas A., Diabetes care . 2018,第7期

机译：Liraglutide对参与者的淀粉酶，脂肪酶和急性胰腺炎的影响超重/肥胖，令人肥胖症，前一种糖尿病或2型糖尿病：来自规模临床发展计划的汇总数据的二次分析（Vol 40，PG 839,2017）
2. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program [J] . Steinberg William M., Rosenstock Julio, Wadden Thomas A., Diabetes care . 2017,第7期

机译：Liraglutide对淀粉酶，脂肪酶和急性胰腺炎的淀粉酶，脂肪酶和急性血糖，前脂肪酸或2型糖尿病中的影响：来自规模临床发展计划的汇总数据的二次分析
3. A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program. Diabetes Care 2017;40:1331-1341 [J] . Ely Elizabeth K., Gruss Stephanie M., Luman Elizabeth T., Diabetes care . 2017,第11期

机译：预防2型糖尿病的国家努力：CDC国家糖尿病预防计划的参与者级别评估。糖尿病护理2017; 40：1331-1341
4. Erratum. Impact of Liraglutide on Amylase Lipase and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia Prediabetes or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839–848 [O] . William M. Steinberg, Julio Rosenstock, Thomas A. Wadden, 2018

机译：勘误表。利拉鲁肽对超重/肥胖和血糖正常前驱糖尿病或2型糖尿病参与者的淀粉酶脂肪酶和急性胰腺炎的影响：来自SCALE临床开发计划的汇总数据的二次分析。 2017年糖尿病护理； 40：839–848
5. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program [O] . William M. Steinberg, Julio Rosenstock, Thomas A. Wadden, 2017

机译：Liraglutide对淀粉酶，脂肪酶和急性胰腺炎的淀粉酶，脂肪酶和急性血糖，前脂肪酸或2型糖尿病中的影响：来自规模临床发展计划的汇总数据的二次分析

Erratum. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839–848

著录项

相似文献

相关主题

期刊订阅